問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2018-05-01 - 2023-05-17
Condition/Disease
SERIOUS INFECTIONS DUE TO GRAM NEGATIVE BACTERIA, INCLUDING METALLO-Β-LACTAMASE (MBL) - PRODUCING MULTIDRUG RESISTANT PATHOGENS, FOR WHICH THERE ARE LIMITED OR NO TREATMENT OPTIONS
Test Drug
PF-06947387 (Aztreonam –Avibactam)
Participate Sites7Sites
Not yet recruiting6Sites
Terminated1Sites
2021-12-04 - 2024-09-30
Participate Sites3Sites
Recruiting3Sites
2019-08-22 - 2021-06-16
Terminated7Sites
2008-11-01 - 2011-05-31
Participate Sites2Sites
Terminated2Sites
2010-08-01 - 2012-12-31
Terminated3Sites
Participate Sites1Sites
2010-11-01 - 2021-12-31
2007-11-01 - 2008-12-31
Participate Sites5Sites
Terminated5Sites
2010-04-01 - 2012-04-30
2012-01-01 - 2013-06-30
Participate Sites4Sites
Terminated4Sites
全部
